Werewolf Therapeutics Inc is a pioneering biopharmaceutical firm focused on cancer treatment through innovative immune system stimulation. Utilizing its unique PREDATOR platform, the company creates ...

Werewolf Therapeutics Inc. HOWL shares are trending on Friday. Shares of the Massachusetts-based clinical-stage biopharmaceutical company surged 89.94% to $0.82 in after-hours trading on Thursday, ...

Werewolf Therapeutics (HOWL) stock exploded higher on Friday morning after management said the company has agreed to a definitive all-stock merger with Ambros Therapeutics. The combined company will ...

Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

Detailed price information for Werewolf Therapeutics Inc (HOWL-Q) from The Globe and Mail including charting and trades.

Detailed price information for Werewolf Therapeutics Inc (HOWL-Q) from The Globe and Mail including charting and trades.